Glecaprevir/pibrentasvir for 8 Weeks in Treatment-Naïve Patients with Chronic HCV Genotypes 1-6 and compensated cirrhosis: the EXPEDITION-8 Trial

Publication Type:

Journal Article

Source:

J Hepatol, Volume 72, Issue 3, p.441-449 (2020)
Top